Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 02:21PM ET
42.87
Dollar change
-1.22
Percentage change
-2.77
%
IndexRUT P/E- EPS (ttm)-0.14 Insider Own1.51% Shs Outstand77.49M Perf Week-0.05%
Market Cap3.32B Forward P/E71.18 EPS next Y0.60 Insider Trans-11.59% Shs Float76.33M Perf Month19.32%
Income-9.27M PEG- EPS next Q0.11 Inst Own106.24% Short Float3.77% Perf Quarter50.05%
Sales425.33M P/S7.81 EPS this Y135.29% Inst Trans2.80% Short Ratio3.62 Perf Half Y100.23%
Book/sh15.18 P/B2.82 EPS next Y67.30% ROA-0.77% Short Interest2.88M Perf Year68.85%
Cash/sh3.54 P/C12.12 EPS next 5Y- ROE-0.83% 52W Range18.61 - 44.50 Perf YTD55.83%
Dividend Est.- P/FCF58.82 EPS past 5Y-10.52% ROI-0.78% 52W High-3.66% Beta1.70
Dividend TTM- Quick Ratio4.79 Sales past 5Y34.42% Gross Margin64.93% 52W Low130.36% ATR (14)1.67
Dividend Ex-Date- Current Ratio5.08 EPS Y/Y TTM79.63% Oper. Margin2.65% RSI (14)65.24 Volatility3.27% 4.71%
Employees815 Debt/Eq0.02 Sales Y/Y TTM23.95% Profit Margin-2.18% Recom1.67 Target Price42.90
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q147.47% Payout- Rel Volume0.59 Prev Close44.09
Sales Surprise5.50% EPS Surprise486.42% Sales Q/Q28.58% EarningsNov 06 AMC Avg Volume795.23K Price42.87
SMA206.97% SMA5018.05% SMA20058.14% Trades Volume357,987 Change-2.77%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade Goldman Buy → Neutral $38 → $37
Nov-15-24Initiated Wolfe Research Outperform $50
Oct-16-24Initiated UBS Buy $43
Oct-10-24Initiated Guggenheim Buy $40
Feb-23-24Reiterated Needham Buy $30 → $33
Jan-18-23Downgrade Raymond James Outperform → Mkt Perform
Jan-05-23Initiated Scotiabank Sector Outperform $33
Jan-07-22Initiated Stephens Overweight $52
Nov-18-21Resumed Goldman Buy $60
Jun-15-21Initiated Raymond James Outperform $45
Nov-27-24 04:51PM
Nov-07-24 10:01AM
Nov-06-24 06:10PM
05:05PM
04:05PM
07:43AM Loading…
Nov-05-24 07:43AM
Oct-30-24 05:00PM
Oct-16-24 06:43PM
Oct-09-24 05:07PM
Oct-02-24 05:02PM
08:20AM
Sep-15-24 08:45AM
Sep-06-24 07:01PM
Sep-05-24 11:31AM
Sep-04-24 04:05PM
09:50AM Loading…
09:50AM
Aug-26-24 05:30PM
09:00AM
04:36AM
Aug-19-24 09:55AM
Aug-15-24 09:50AM
Aug-14-24 09:15AM
Aug-09-24 07:22PM
Aug-08-24 09:09AM
Aug-07-24 02:08PM
Aug-06-24 06:25PM
05:24PM
04:05PM
Jul-24-24 10:57AM
Jul-19-24 12:01AM
05:00PM Loading…
Jul-17-24 05:00PM
04:48AM
Jun-21-24 09:55AM
Jun-06-24 11:31AM
Jun-03-24 04:05PM
May-29-24 09:55AM
09:30AM
May-28-24 09:31AM
08:47AM
08:32AM
May-23-24 10:00AM
May-22-24 04:05PM
May-21-24 09:59AM
May-15-24 05:04PM
May-13-24 09:55AM
May-08-24 03:13PM
08:55AM
07:12AM
03:48AM
May-07-24 10:55PM
06:13PM
06:00PM
04:05PM
May-06-24 04:05PM
Apr-22-24 05:00PM
08:30AM
Apr-16-24 08:30AM
Apr-02-24 10:33AM
Feb-27-24 05:55PM
Feb-26-24 03:20PM
Feb-23-24 11:10AM
07:43AM
07:37AM
Feb-22-24 06:05PM
05:03PM
04:40PM
04:05PM
Feb-21-24 05:00PM
Feb-08-24 08:00AM
Feb-06-24 08:15AM
Jan-08-24 08:00AM
Dec-12-23 04:30PM
Dec-01-23 04:05PM
Nov-29-23 08:30AM
Nov-22-23 08:30AM
Nov-08-23 04:39PM
Nov-07-23 04:57PM
04:05PM
04:00PM
Nov-02-23 08:15AM
Oct-27-23 08:30AM
Oct-26-23 02:50PM
Oct-17-23 08:15AM
Oct-16-23 10:43AM
Oct-12-23 09:00AM
Oct-04-23 04:05PM
Sep-28-23 04:05PM
08:15AM
Sep-27-23 09:00AM
Sep-21-23 04:05PM
Sep-07-23 04:05PM
Sep-06-23 08:15AM
Sep-02-23 06:15AM
Aug-29-23 08:15AM
Aug-22-23 08:15AM
Aug-15-23 04:15PM
Aug-08-23 06:05PM
04:55PM
04:05PM
Aug-01-23 08:15AM
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leite JohnChief Commercial Officer-CLIADec 03 '24Sale43.251,05045,40873,810Dec 04 04:59 PM
Chambers RebeccaChief Financial OfficerDec 03 '24Sale43.237,000302,622114,037Dec 04 04:59 PM
Wygant JonathanVP, Chief Accounting OfficerDec 03 '24Sale43.3695641,45240,270Dec 04 04:59 PM
PHILLIP G FEBBOOfficerDec 04 '24Proposed Sale43.662,623114,520Dec 04 04:38 PM
ANN MCGUIREOfficerDec 04 '24Proposed Sale43.6618,699816,398Dec 04 04:35 PM
REBECCA CHAMBERSOfficerDec 03 '24Proposed Sale44.127,527332,091Dec 03 04:32 PM
JOHN LEITEOfficerDec 03 '24Proposed Sale44.121,05046,326Dec 03 04:31 PM
Wygant JonathanVP, Chief Accounting OfficerNov 27 '24Sale42.895,032215,83442,313Nov 29 02:28 PM
EASTHAM KARINDirectorNov 19 '24Sale38.3414,731564,76818,497Nov 21 04:36 PM
KARIN EASTHAMDirectorNov 19 '24Proposed Sale36.7114,731540,775Nov 19 04:23 PM
Chambers RebeccaChief Financial OfficerNov 12 '24Sale38.3415,275585,663124,501Nov 14 04:35 PM
EPSTEIN ROBERT SDirectorNov 12 '24Option Exercise8.0415,000120,60059,598Nov 14 04:35 PM
EPSTEIN ROBERT SDirectorNov 12 '24Sale38.3215,000574,83044,598Nov 14 04:35 PM
ROBERT S EPSTEINDirectorNov 12 '24Proposed Sale38.8915,000583,350Nov 12 04:29 PM
REBECCA CHAMBERSOfficerNov 12 '24Proposed Sale38.8915,275594,045Nov 12 04:29 PM
JONES EVAN/ FADirectorSep 19 '24Sale35.235,173182,2630Sep 23 04:23 PM
Leite JohnChief Commercial Officer-CLIASep 04 '24Sale29.785,479163,15976,174Sep 06 04:18 PM
JOHN LEITEOfficerSep 04 '24Proposed Sale30.295,479165,959Sep 04 04:17 PM
JONES EVAN/ FADirectorAug 13 '24Option Exercise10.418,48688,33954,800Aug 14 05:09 PM
JONES EVAN/ FADirectorAug 13 '24Sale32.2027,188875,5655,173Aug 14 05:09 PM
JONES EVAN/ FADirectorAug 13 '24Sale32.2020,457658,80134,343Aug 14 05:09 PM
JONES EVAN/ FADirectorAug 12 '24Sale30.001013,03132,361Aug 14 05:09 PM
JONES EVAN/ FADirectorAug 12 '24Sale30.01992,97146,314Aug 14 05:09 PM
JONES EVAN/ FADirectorAug 09 '24Option Exercise10.413003,12347,445Aug 13 04:38 PM
JONES EVAN/ FADirectorAug 09 '24Sale30.031,03230,99046,413Aug 13 04:38 PM
JONES EVAN/ FADirectorAug 09 '24Sale30.0374622,40232,462Aug 13 04:38 PM
Holstein JensDirectorAug 07 '24Sale29.005,000145,00027,878Aug 09 04:47 PM
JONES EVAN/ FADirectorAug 07 '24Option Exercise10.411,21412,63850,288Aug 09 04:47 PM
JONES EVAN/ FADirectorAug 07 '24Sale30.325,108154,88345,180Aug 09 04:47 PM
Evan JonesDirectorAug 07 '24Proposed Sale27.0559,9041,620,403Aug 07 07:52 PM
EASTHAM KARINDirectorJul 16 '24Sale25.007,500187,50033,228Jul 18 06:25 PM
Leite JohnChief Commercial Officer-CLIAJul 16 '24Sale25.001,27731,92582,968Jul 18 06:25 PM
Holstein JensDirectorJul 16 '24Sale24.505,000122,50032,878Jul 18 06:25 PM
EASTHAM KARINDirectorJun 11 '24Sale20.593,87079,68329,255Jun 13 04:24 PM
Bhanji MunaDirectorJun 10 '24Sale20.323,87078,63423,105Jun 11 04:22 PM
EASTHAM KARINDirectorJun 07 '24Option Exercise10.412,50026,02535,625Jun 11 04:21 PM
EASTHAM KARINDirectorJun 07 '24Sale20.972,50052,42533,125Jun 11 04:21 PM
Bhanji MunaDirectorMay 28 '24Sale21.001,53932,31926,975May 30 04:41 PM
EASTHAM KARINDirectorApr 01 '24Option Exercise13.1910,000131,90043,125Apr 02 04:17 PM
EASTHAM KARINDirectorApr 01 '24Sale21.6510,000216,52833,125Apr 02 04:17 PM
JONES EVAN/ FADirectorMar 01 '24Option Exercise13.1910,000131,90047,601Mar 05 05:28 PM
JONES EVAN/ FADirectorMar 01 '24Sale24.3610,000243,59937,601Mar 05 05:28 PM